(Q42259021)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24170683%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Assessment of current criteria for primary nonresponse in chronic hepatitis B patients receiving entecavir therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24170683%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24170683%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Young-Joo Yang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24170683%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Kang Mo Kim

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24170683%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Young-Suk Lim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24170683%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Han Chu Lee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24170683%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

language of work or name

English

0 references

publication date

25 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24170683%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24170683%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24170683%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24170683%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

1303-1310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24170683%20AND%20SRC:MED&resulttype=core&format=json

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

28 February 2020

cites work

1 reference

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load

21 January 2018

1 reference

Hepatitis B e antigen and the risk of hepatocellular carcinoma

21 January 2018

1 reference

Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature

21 January 2018

1 reference

The relationship between HBV-DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B.

21 January 2018

1 reference

Obstruction at middle hepatic venous tributaries in modified right lobe grafts after living-donor liver Transplantation: diagnosis with contrast-enhanced US.

21 January 2018

1 reference

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

21 January 2018

1 reference

Hepatitis B virus DNA levels at week 4 of lamivudine treatment predict the 5-year ideal response

21 January 2018

1 reference

Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B.

21 January 2018

1 reference

Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B.

21 January 2018

1 reference

Telbivudine versus lamivudine in patients with chronic hepatitis B

21 January 2018

1 reference

Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides

21 January 2018

1 reference

Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.

21 January 2018

1 reference

Chronic hepatitis B: update 2009

21 January 2018

1 reference

Adherence to nucleos(t)ide analogues for chronic hepatitis B in clinical practice and correlation with virological breakthroughs.

21 January 2018

1 reference

Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone.

21 January 2018

1 reference

Chronic hepatitis B virus infection. Viral replication and patterns of inflammatory activity: serological, clinical and histological correlations.

21 January 2018

1 reference

Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.

21 January 2018

1 reference

Treatment of hepatitis B e antigen positive chronic hepatitis with telbivudine or adefovir: a randomized trial

21 January 2018

1 reference

Lamivudine for patients with chronic hepatitis B and advanced liver disease

21 January 2018

1 reference

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

21 January 2018

1 reference

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

21 January 2018

1 reference

Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response

21 January 2018

1 reference

Three Years of Continuous Entecavir Therapy in Treatment-Naïve Chronic Hepatitis B Patients: VIRAL Suppression, Viral Resistance and Clinical Safety

21 January 2018

1 reference

Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients

21 January 2018

1 reference

7 January 2021

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

1 reference

7 January 2021

Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B

1 reference

7 January 2021

Comparison of multiplex restriction fragment mass polymorphism and sequencing analyses for detecting entecavir resistance in chronic hepatitis B

1 reference

7 January 2021

Early virological suppression is associated with good maintained response to adefovir dipivoxil in lamivudine resistant chronic hepatitis B

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.26910

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24170683%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference